NeoStem is also a PCT client, enabling us to cost-effectively and efficiently develop our own cell therapy products, as well as translate our own research and development efforts, capabilities and proprietary technologies into stable, reproducible, well-characterized cell therapy products, including product candidates for NeoStem’s CD34 Cell Program and T Regulatory Cell program.
- 30,000+ products manufactured
- 18,000+ products stored
- 14,000+ product deliveries made
- 6,000+ patients treated with PCT’s products
- 100+ clients with proven results
- 50+ regulatory filings in US & EU
- 30+ technology transfers performed
- Proven successful regulatory track record
To be the CDMO of choice for the full cycle of development through commercialization, by providing the highest quality, most cost effective and innovative solutions to our Clients.
Customer Service Commitment
PCT’s Client-focused service model is designed to deliver outstanding customer service to its clients. We strive to gain the clients’ trust and to develop long-term relationships built upon satisfaction with the PCT experience.
To learn more, please visit www.pctcelltherapy.com